全文获取类型
收费全文 | 240121篇 |
免费 | 17182篇 |
国内免费 | 818篇 |
专业分类
耳鼻咽喉 | 2664篇 |
儿科学 | 6372篇 |
妇产科学 | 4861篇 |
基础医学 | 31445篇 |
口腔科学 | 4980篇 |
临床医学 | 23079篇 |
内科学 | 50665篇 |
皮肤病学 | 3785篇 |
神经病学 | 23341篇 |
特种医学 | 8037篇 |
外国民族医学 | 15篇 |
外科学 | 36928篇 |
综合类 | 3703篇 |
现状与发展 | 2篇 |
一般理论 | 307篇 |
预防医学 | 21509篇 |
眼科学 | 4902篇 |
药学 | 16394篇 |
1篇 | |
中国医学 | 416篇 |
肿瘤学 | 14715篇 |
出版年
2023年 | 1023篇 |
2022年 | 1610篇 |
2021年 | 3906篇 |
2020年 | 2456篇 |
2019年 | 3816篇 |
2018年 | 4744篇 |
2017年 | 3788篇 |
2016年 | 4147篇 |
2015年 | 4866篇 |
2014年 | 6941篇 |
2013年 | 10111篇 |
2012年 | 15198篇 |
2011年 | 16562篇 |
2010年 | 9151篇 |
2009年 | 8249篇 |
2008年 | 15279篇 |
2007年 | 16233篇 |
2006年 | 15649篇 |
2005年 | 16066篇 |
2004年 | 15350篇 |
2003年 | 14374篇 |
2002年 | 13837篇 |
2001年 | 2513篇 |
2000年 | 2044篇 |
1999年 | 2647篇 |
1998年 | 3082篇 |
1997年 | 2634篇 |
1996年 | 2370篇 |
1995年 | 2112篇 |
1994年 | 1926篇 |
1993年 | 1793篇 |
1992年 | 1474篇 |
1991年 | 1451篇 |
1990年 | 1308篇 |
1989年 | 1185篇 |
1988年 | 1219篇 |
1987年 | 1226篇 |
1986年 | 1189篇 |
1985年 | 1289篇 |
1984年 | 1616篇 |
1983年 | 1596篇 |
1982年 | 1910篇 |
1981年 | 1738篇 |
1980年 | 1628篇 |
1979年 | 940篇 |
1978年 | 1058篇 |
1977年 | 1030篇 |
1976年 | 915篇 |
1975年 | 799篇 |
1974年 | 785篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
Sixty-three mallards were fed one of ten poly(methyl methacrylate) based synthetic grit formulations containing varying concentrations of a proposed wildlife contraceptive (nicarbazin), plasticizer (acetyl tributylcitrate) and/or cross-linking agent (1,4-butanediol diacrylate). Release characteristics of the contraceptive agent were monitored for the purpose of developing a contraceptive formulation for control of pest waterfowl in urban settings. The addition of plasticizer increased the erosion rate (t(1/2)=0.97-2.85 days), cross-linking the polymer matrix slightly decreased the erosion rate (t(1/2)=4.45-5.05 days) and increasing the concentration of the contraceptive agent increased the erosion rate (t(1/2)=3.3 and 9.9 days at 60% and 7.5% active ingredient, respectively). The larger and smaller grit pieces had longer half lives at 11.0 and 11.6 days, respectively while the mid sized grit had a half life of 4.95 days. Control grit had a half life of 12.7 days based on weight loss. Analysis of blood and feces for monitoring release from the grit and approximate indirect plasma levels of the active ingredient proved feasible. 相似文献
22.
23.
24.
25.
26.
Peter D. Le Roux David S. Jardine Paul M. Kanev John D. Loeser 《Child's nervous system》1991,7(1):34-39
We reviewed the results of all pediatric patients undergoing intracranial pressure (ICP) monitoring in a 2-year period at our institution. The outcome of patients suffering hypoxia or ischemic injuries (HII) is compared to those suffering non-hypoxic or non-ischemic injuries (NHII). Thirty-four patients had ICP monitors placed during the study period. Inconplete patient information led to the exclusion of 5 patients. An additional 5 patients were excluded because no measures to control ICP were taken after the monitor was placed. Twenty-four patients required treatment for raised ICP (hyperventilation, 24; mannitol, 19; barbiturate coma, 6). Admission Glasgow Coma Score in patients suffering HII (median score 5) and NHII (median score 6) were not significantly different (Mann-Whitney U Test). Only 2 of 8 patients with HII were near-drowning vietims. The remaining 6 had HII from other causes (5 survivors of various forms of asphyxia and 1 of cardiac arrest). All 8 patients had poor outcomes (1 severely disabled; 7 died). The 16 patients with NHII had a variety of diagnoses (6 trauma, 5 encephalitis, 4 bacterial meningitis, 1 diabetic ketoacidosis). Among these, 6 had good outcomes and 10 poor outcomes (2 severely disabled, 2 vegetative, and 6 died). The difference in outcome between patients with NHII and HII is significant at P=0.059 (Fischer Exact test). Patients with NHII may benefit from ICP monitoring. Patients with HII from near-drowning and other causes did not appear to benefit from ICP monitoring and interventions directed at controlling ICP. 相似文献
27.
28.
Effect of unilateral ureteral occlusion on fibrin deposition in the kidney and renal blood flow during intravascular coagulation in rat 总被引:1,自引:0,他引:1
The effect of unilateral ureteral occlusion on fibrin deposition in the kidney and the interrelation of the fibrin deposition and the renal blood flow was studied in rat. Intravascular coagulation in the kidney was induced by infusion of thrombin and inhibition of fibrinolysis with tranexamic acid. The effects unilateral occlusion of the ureter for 1 and 24 h on fibrin deposition and renal blood flow were studied. Fibrin in the kidneys was quantitated by intravenous injection of 125I-labelled fibrinogen 24 h before the experiment. The renal blood flow was measured before and after infusion of thrombin by injection of 85Sr- and 141Ce-labelled microspheres into the left ventricle. After ureteral occlusion for 1 h the deposition of fibrin in the kidneys was unaffected. After 24 h substantially less fibrin deposition was found in the occluded than in the unoccluded kidney (0.3 +/- 0.2 and 5.7 +/- 1.6 mg, respectively; p less than 0.05). Before thrombin infusion the blood flow to the occluded kidney was less than that in the unoccluded kidney (2.1 +/- 0.8 and 3.7 +/- 1.2 ml/min, 100 g body weight, respectively; p less than 0.05). The blood flow after infusion of thrombin was equally reduced in both kidneys. The results contradict the hypothesis that vasoconstriction increases the amount of fibrin in the kidneys in thrombin-induced intravascular coagulation. 相似文献
29.
John M Murkin 《Journal canadien d'anesthésie》2002,49(10):S21-S26
PURPOSE: To review the role of recombinant factor VIIa in anesthetic practice. SOURCE: A review of the published literature. MAIN FINDINGS: The mechanism of action of rFVIIa suggests enhancement of hemostasis limited to the site of injury without systemic activation of the coagulation cascade. In addition to its indication for use in patients with hemophilia, use of rFVIIa for treatment of uncontrolled massive hemorrhage in various peroperative settings appears to be rational, safe, and effective. Published results suggest that in trauma patients rFVIIa may play a role as an adjunctive hemostatic measure in addition to surgical hemostatic techniques There is preliminary evidence that hemorrhagic complications (eg. epistaxis, vaginal bleeding) associated with profound thrombocytopenia can be reversed with rFVIIa even at platelet counts below 10,000 per microL. Various case reports outlining the successful treatment with recombinant factor VIIa of patents experiencing intractable bleeding after valve replacement surgery, and with severe hemorrhage during therapy with left ventricular assist device, indicate the potential therapeutic efficacy of this agent in cardiac surgical procedures. Additionally, rFVIIa has been used successfully for treatment of massive postoperative bleeding following general surgery. CONCLUSIONS: rFVIIa is a novel hemostatic agent that shows promise in non-hemophiliac patents of a significant therapeutic role in variety of coagulopathic and hemorrhagic conditions in clinical situations ranging from thrombocytopenia, disseminated intravascular coagulation and transfusion-related coagulopathy, as well as in patients experiencing massive blood loss undergoing orthotopic liver transplantation, cardiac, orthopedic and genitourinary surgery. 相似文献
30.
John Hawk 《Photodermatology, photoimmunology & photomedicine》2002,18(3):146-146